Cabaletta Bio 2024 annual meeting: Bollard and Henriques elected as directors, EY ratified

Cabaletta Bio, Inc.

Stockholders elected Catherine Bollard and Richard Henriques as Class II directors; Bollard received 26,225,488 for, 12,001,379 withheld; Henriques received 37,806,806 for, 433,474 withheld.
Ratification of Ernst & Young LLP as independent auditor for FY2024 passed with 41,355,429 for, 38,098 against, 5,728 abstain.
46,804,820 shares were outstanding as of the April 4, 2024 record date; no other matters voted on.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.